Partner with Urology Alliance
Driving advances in patient care through trusted, scalable clinical research.Urology Alliance Research partners with sponsors to execute high-performing urology clinical trials across a coordinated, multi-site network.
Operating within high-volume, physician-led, urology practices, we deliver expedited study activation, accelerated enrollment, and uncompromising quality at every stage of clinical execution.
Why Urology Alliance?
Network Efficiency
Access multiple established urology sites through a centralized research infrastructure, sponsors gain streamlined access to multiple urology sites.
- Single coordinated engagement
- Standardized processes
- Consolidated budget and contract negotiation process
- Streamlined feasibility
- Accelerated start up
- Centralized Regulatory and Compliance Oversight
Therapeutic Depth
Our experienced investigators conduct trials across the full spectrum of urologic disease, including:
- Benign Prostatic Hyperplasia (BPH)
- Bladder Cancer
- Prostate Cancer
- Kidney and Ureteral Conditions
- Reproductive Health and sexual function
- Female Urology
- Overactive Bladder and Urge Incontinence
- Other Urologic Cancers
We support Phase I–IV drug, device, and post-market studies.
Built-In Infrastructure
Our sites operate within established clinical practices supported by:
- Dedicated research coordinators
- Advanced Imaging (PET, CT, MRI, XRAY)
- Ambulatory Surgical Centers and Dedicated Procedural Suites
- In-house laboratory and advanced pathology
- Linear Accelerators
- Established Medical Oncology Support
Patient Access at Scale
Urology Alliance research sites are embedded in practices that serve large, diverse patient populations across multiple regions.
Sponsors benefit from:
- High-volume oncology and benign urology populations
- Established referral networks
- Integrated cancer and specialty centers
- Strong physician-to-patient continuity
Physicians in Network: 90+
# of Research Investigators: 70+
Find A Location Near You
Filter Locations
No locations match your search criteria.
Performance That Matters
We focus on measurable execution.
Trial Portfolio
- Ongoing Studies: 150+
- Completed Studies: 300+
- Phase I–IV Representation
Enrollment Metrics
- Average Enrollment per Trial: 25+
- Screen-Fail Rate: <5%
- Top Quartile Recruitment Performance
Activation Timelines
- Feasibility Response- 48 hours
- Contract Execution: 2- 3 weeks
- SIV to FPV: < 1 week
Sponsor Retention
- Repeat Sponsor Rate: 99%
- Multi-Site Engagement Across Network: 100%
Network Advantage
Our coordinated model enables:
- Accelerated enrollment across sites nationwide
- Consistent, high-quality data
- Simplified communication pathways
- Scalable multi-site deployment
- Operational excellence
Research is embedded within clinical care, not layered on top of it, ensuring operational stability and investigator engagement.
Leadership
Clinical research at Urology Alliance is led by experienced physician-investigators committed to advancing standards of care while maintaining patient safety and regulatory integrity.
Let’s Advance Patient Care
If you are seeking a research network with operational discipline, therapeutic expertise, and scalable performance, Urology Alliance is ready to collaborate.
